Treating Post-Lyme Disease Syndrome With Acetogenins

Optimal Health Research

Status and phase: Completed; Phase 2; Phase 1

Conditions: Post-Lyme Disease Syndrome (PLDS)

Treatments: Other: Inert Brown powder; Dietary Supplement: ReaLife+ (RLP)

Study type: Interventional

Funder types: Other

Identifiers

NCT04078841

RLP042019

Details and patient eligibility

About

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

Full description

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. A positive Western Blot for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.

2. Must be able to swallow and mixed powder drink.

Exclusion criteria

1. Non Positive Western Blot test.

2. Positive Western Blot test where the indivual has not been treated with antibiotics.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

30 participants in 3 patient groups, including a placebo group

ReaLife+ (RLP)

Active Comparator group

Description:

Dietary Supplement: ReaLife+ (RLP) RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids

Treatment:

Dietary Supplement: ReaLife+ (RLP)

Inert Brown Powder

Placebo Comparator group

Description:

Brown powder Inert brown powder to look similar to RLP

Treatment:

Other: Inert Brown powder

Control

No Intervention group

Description:

Control